At Kizer Pharmacy, we offer science-informed supplement recommendations tailored to your needs
Furthermore, while some studies failed to identify a significant correlation between GLP-1RA therapy and overall AF, interestingly, they noted that oral semaglutide exerted a potential protective effect against AF, whereas dulaglutide showed an opposing trend (albeit non-robust), with other GLP-1RAs displaying no significant association with AF (134)
Semaglutide vs Tirzepatide vs Retatrutide: Receptors Compared The single clearest way to see why stacking Ozempic and retatrutide is redundant is to line up the receptor targets of the three major incretin classes: Compound Class Receptors Targeted Why It Matters Semaglutide (Ozempic) Single agonist GLP-1 (1 receptor) Appetite and glycemic control through one pathway Tirzepatide (Mounjaro/Zepbound) Dual agonist GIP + GLP-1 (2 receptors) Adds GIP for greater metabolic effect than GLP-1 alone Retatrutide (LY3437943) Triple agonist GIP + GLP-1 + Glucagon (3 receptors) Adds glucagon-driven energy expenditure
It could be transformative for patients who avoid injections, with possible approval around 20252026
It acts like the bodys natural GLP-1 hormone, which increases insulin release, reduces glucagon, and slows digestion